Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2004

View Archived Issues

Topical NO donor DS1 increases vaginal blood flow in rats

Rockwell receives grant for proprietary dialysate iron therapy study

Positive Life-Star and Health-Star phase III results due shortly

Fujisawa enters option agreement for distribution of Ampligen

Inflammation and elevated C-reactive protein increase the risk of colon cancer

Oral rhIL-11 improves mucosal inflammation in chronic colitis model

NO plays an important role in improving insulin action by pioglitazone

Karo Bio highlights developments over past year

Immunomedics reports continued growth of product pipeline during Q2 FY 2004

New macrolide-containing conjugates and their use reported by Pliva

Two series of macrolide-containing antiinflammatory agents developed at Pliva

Researchers at Karo Bio and BMS present novel thyroid receptor modulators

New mitotic kinesin KSP inhibitors jointly reported by Cytokinetics and GSK

Novel antibacterial cephalosporins covered by Sandoz patent

Novel antiproliferative agents in early development at Bayer

AstraZeneca scientists identify novel CRTh2 receptor modulators

Cytopia and Myomatrix enter cardiovascular collaboration

U. Pittsburgh Medical Center acquires RheoGene

BioMarin initiates PKU clinical program

Schwarz Pharma obtains rights to PAC-20030

Research at CSIRO shows Relenza effective against bird flu in laboratory

Thalomid sNDA accepted for review

Generex collaboration to develop DNA vaccine against SARS

Enrollment extended in AIM study of I2S in Hunter syndrome

NIH studies GPI-1485 in phase II Parkinson's trial

Nabi reports preliminary results from phase I/II Cicavir study

Oral phenoxodiol evaluated in phase I trial for cervical cancer

Vidaza NDA accepted for filing

NDA submission for six-month Eligard product

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...